Bio LL, Siu A, Poon CY. Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol. 2011 Nov;31(11):692-701. doi: 10.1038/jp.2011.116.
McCollum M, Stringer KA, Wittkowsky AK, Young S, Spinler SA. Discrepencies in identification of bleeding events after percutaneous coronary intervention. Pharmacother 2007;27:36-40.Peterman CM. Kolansky DM, Spinler SA. prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study. Pharmacother 2006;26:1086-90.
Peterman CM. Kolansky DM, Spinler SA. prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study. Pharmacother 2006;26:1086-90.
de Denus S, Al-Jazairi A, Jessup M, Stanek EJ, Spinler SA. Dyslipidemias and HMG-CoA reductase inhibitor prescription in heart transplant patients. Ann Pharmacother 2004; 38:1136-31.deDenus S, Spinler S, Peterson, AM. Statins and liver toxicity: A meta-analysis. Pharmacotherapy, 2004; 24:584-91
Spinler SA, Inverso SM, Cohen M, Goodman SG, Stringer KA, Antman EM for the ESSENCE and TIMI 11B Investigators. Safety and efficacy of unfractionated heparin versus enoxaparin in obese patients and patients with severe renal impairment: Analysis from the ESSENCE and TIMI 11B studies. Am Heart J 2003;146:33-41.
Papshev D, Peterson AM. Extent of electronic prescribing implementation as perceived by MCO pharmacy managers. JMCP. 2002; 8:41-7.
Hilleman DE, Spinler SA. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. Pharmacother 2002;22:66-74.
Spinler SA, Al-Jazairi AS, Cheng JWM, Kapoor S, Kobrin S, Shaw L. Predictive performance of two digoxin assays in subjects with various degrees of renal function. Therapeutic Drug Monitoring 2000;22:729-736.
Cawley MJ, Wittbrodt ET, Boyce EG, Skaar DJ. Potential risk factors associated with thrombocytopenia in a surgical intensive care unit. Pharmacotherapy.19 (1): 108 – 13, 1999 Jan.
Cawley MJ, Skaar DJ, Anderson HL, Hanson CW. Mechanical ventilation and pharmacological strategies for acute respiratory distress syndrome. Pharmacotherapy. 18(1): 140 – 55, 1998 Jan-Feb.
Baetz BE, Gerstenfeld EP, Kolansky DM, Spinler SA. Bivalirudin use during radiofrequency catheter ablation procedures in two patients with a history of heparin-induced thrombocytopenia. Pharmacotherapy 2010;30(9):952.
Makkar K, Wilensky RL, Julien MB, Herrmann HC, Spinler SA. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents: review of the literature and management strategies. Ann Pharmacother 2006 (In Press).
Prom R, Spinler SA. The role of apixaban for venous and arterial thromboembolic disease. Ann Pharmacother 2011;45:1262-83.
Bio LL, Willey VJ, Poon CY. Comparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children. J Pediatr Pharmacol Ther. 2011 Jul;16(3):191-8.
Patel H, Heverin E, Earl G, Ascher S, Burks E. Satisfaction of medical information specialists with the after-hours call service provided by pharmaceutical companies. Drug Information Association Journal, manuscript. 2011 (In Press).
Abraham M, Earl G, Hajjar E, Heverin E. A survey about decision-making criteria to support a medical information booth at scientific meetings. Drug Information Journal 2010;44(4): 351-8.
Abraham M, Earl GL. Health literacy: do your patients understand what you tell them? Pennsylvania Pharmacist, September/October 2009: 9-11.
Baetz BE, Spinler SA. Dabigatran: An oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases. Pharmacother 2008;28:1354-73.
Hermosilo AJ, Spinler SA. Aspirin, clopidogrel and warfarin: Is the combination appropriate and effective or inappropriate and too dangerous? Ann Pharmacother 2008;42:790-805.
Peterman C, Sanoski CA. Tecadenoson: a novel, selective A1 adenosine receptor agonist. Cardiol Rev 2005;13(6):315-21.
Spinler SA, Young SA. Heparin-induced thrombocytopenia [essay]. Cardiosource Web Site, American College of Cardiology Foundation and Elsevier, Inc. Feb 2003. Available at http://www.cardiosource.com/news/hot_topics. Accessed March 31, 2003.
Spinler SA, Inverso SM. Update in strategies to improve thrombolysis for acute myocardial infarction. Pharmacother 2001;21:691-716
Papshev D, Peterson AM. Electronic prescribing in ambulatory practice: promises, pitfalls and solutions. Am J Man Care. 2001; 7:100-105.
Spooner JJ, Peterson AM. Corporate compliance. Online Publication. www.ross.com/CE/Corporatecompliance. July 2001.
Inverso SM, Spinler SA. Antithrombotic agents for secondary prevention of cardioembolic and noncardioembolic stroke – another viewpoint. Pharmacother 2001;21:1021-22.
Spinler SA, Rajyaguru M. Injectable anticoagulation considerations in special patient populations: chronic kidney disease and obesity. Fang M, ed. In: Inpatient anticoagulation. Fang M, ed. New Jersey: Wiley; 2011. p. 241-290.
Spinler SA, de Denus S. Acute coronary syndromes. In : DiPiro JT, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy 7th Edition. New York: McGraw-Hill; 2008. p. 291-320.
Spinler SA, de Denus S. Acute coronary syndromes. In: Chisholm-Burns M, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, Rotschafer JC, DiPiro JT, eds. Pharmacotherapy Principles and Practice. New York: McGraw-Hill;2007. p. 83-105.
Wittbrodt ET, Eappen-Abraham T. Bronchitis and pneumonia. In: Arcangelo G, Peterson AM, eds. Pharmacotherapeutics for advanced practice. Philadelphia: Lippincott Williams and Wilkins, 2001:320-34.
Spooner JJ, Mistry S. The economics of therapeutics. In: Arcangelo VP, Peterson AM, editors. Pharmacotherapeutics for advanced practice: a practical approach. Lippincott, Williams & Wilkins, Philadelphia, PA. Spring 2001.